Schedule 13G ownership disclosure
Freeline Therapeutics Holdings plc
Security class unavailable · CUSIP: 35655L107
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,000,000
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-000996
- Form type
- SC 13G
- Filer
- Freeline Therapeutics Holdings plc
- CIK
- CIK 1810031
- Filed
- Jan 31, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership